-by Susie Bragg, RN BSN (Nurse Educator)
If you haven’t heard of “Sema” yet, you certainly will as this relatively new weight loss miracle transforms appetite suppression in an entirely different way. In fact, Svelte Medical Director, Richard Bragg, MD has lost close to 70 pounds on the weekly injection since August of 2022. How long the emergency compounding order from the FDA will last is anybody’s guess however Novo Nordisk is promising to meet the market demand now and pressuring the US to cease and desist with the compounding of Semaglutide immediately. When this happens, Svelte Medical is committed to providing alternative GLP-1 injection therapy to it’s clients and will pivot to alternative therapies. Until the pharmacies are restricted from compounding Semaglutide, Svelte will continue to offer the therapy.
If YOU are the least bit interested in seeing what Semaglutide can do for your waistline, we recommend making an appointment as soon as possible since we have no idea when the compounders will be ordered to cease and desist. We hope we have time because at Svelte, we are completely thrilled with the results our clients are experiencing!
Side effects include nausea, cramping, constipation, gas, diarrhea & loss of appetite. The drug is titrated to acclimate the client’s body to the treatment with minimal side effects. At Svelte, your first “starter” vial of Semaglutide is a very low dose and 90% of our clients report minimal side effects on the first vial at the lowest dose. The second vial is stronger and this is where we see significant weight loss. The treatment schedule can be seen here:
https://sveltemd.com/semaglutide-weight-loss-orlando/
To schedule an appointment or find out more, call us at (407)804-5200